Kaiser Karim is a Senior Research Scientist specializing in Target Validation at Shift Bioscience since May 2025. Previously, Kaiser held the role of Senior Scientist at bit.bio from November 2019 to March 2025, leading high-throughput genetic screening in human iPSCs and identifying rare gene targets for different cell types. Kaiser also contributed to a proof-of-concept Perturb-seq screen in human iPSC-derived neurons and played a significant role in data collection for a $40M Series B fundraising round. Earlier in 2013, Kaiser served as a Laboratory Demonstrator at Monash University Malaysia, co-supervising undergraduate biochemistry students. Kaiser earned a PhD in Clinical Neurosciences from the University of Cambridge and holds a BSc and Honours Degree in Medical Bioscience from Monash University Malaysia, along with a Pre-University qualification from Sunway University.
This person is not in any teams
This person is not in any offices